Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenshen Yangxue Granule is a Traditional Chinese Medicine (TCM) formulation primarily used in the treatment of female reproductive disorders, including diminished ovarian function and infertility. Developed and utilized by institutions such as the Beijing Obstetric & Gynecology Hospital, it is often integrated into clinical protocols alongside Western medicine to enhance the efficacy of ovulation induction. The formulation is designed based on TCM principles to warm the kidney and nourish the blood, which are believed to support follicular development and improve the pelvic microenvironment for conception.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wenshen yangxue granule.